Loading clinical trials...
Loading clinical trials...
Fish Oil Lipid Emulsion for the Treatment of Parenteral-Nutrition-Associated Liver Disease in Infants
This is a single-assignment study to evaluate whether Omegaven (IV fish oil) is effective at treating liver disease in children on long-term IV nutrition.
Children up to 18 years of age, on parenteral nutrition, with a direct bilirubin level of 2 mg/dL or greater will be eligible to receive Omegaven at a maximum dose of 1 g/kg/day. Up to 200 children will be eligible for enrollment. Direct bilirubin levels and other labs will be monitored as well as growth parameters.
Age
0 - 18 years
Sex
ALL
Healthy Volunteers
No
OU Children's Hospital
Oklahoma City, Oklahoma, United States
Start Date
June 1, 2015
Primary Completion Date
September 27, 2018
Completion Date
September 27, 2019
Last Updated
November 25, 2019
63
ACTUAL participants
Omegaven
DRUG
Lead Sponsor
University of Oklahoma
Collaborators
NCT07197944
NCT07191704
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07185919